Kinnate Biopharma inks $98m Series A
San Diego-based Kinnate Biopharma Inc, a biopharmaceutical company, has raised $98 million in Series C financing.
San Diego-based Kinnate Biopharma Inc, a biopharmaceutical company, has raised $98 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination